How Palvella Therapeutics makes money

Period

FY2023

How does Palvella Therapeutics make money? This Sankey traces every dollar of revenue through the income statement — into cost of revenue, R&D, SG&A, and taxes — and shows what's left as profit. Pick any fiscal year, recent quarter, or the trailing twelve months. Straight from SEC filings.

Palvella Therapeutics Inc. · FY2023 · year ended 2023-12-31

Revenue$43MGross profit$43M · 100%Cost of revenue$0 · 0%Operating income$0 · 0%Operating expenses$43M · 100%R&D$9M · 21%SG&A$3M · 7%Other opex$31M · 72%Pre-tax income$19M · 44%Other income$19M · 44%Net income$19M · 44%

Each fiscal year from SEC filings. Percentages are share of revenue, so the green profit nodes read directly as gross / operating / net margin. Line items a company doesn't break out are derived from their siblings so the flows balance; small residuals show as “Other.” For informational purposes only.